Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 0.00% is 100% above its 5-year average of -49.42%, near the high end of its 5-year range (-154.16%–0.00%).
As of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly gross margin; no daily interpolation. Q4 FY2025 (2025-12-31): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
-28.09%
GROSS MARGIN AVG 5Y
-49.42%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+100.00%
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
40.44%
median of 823 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Niki BioSolutions, Inc.
Market Cap
$381125.00
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
-28.09%
5Y Avg
-49.42%
Market Cap
$481786.00
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$556226.00
Gross Margin
20.00%
TTM Avg
28.69%
3Y Avg
28.89%
5Y Avg
35.93%
Market Cap
$108771.00
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$96046.00
Gross Margin
N/A
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$72318.00
Gross Margin
-4864.71%
TTM Avg
-2432.36%
3Y Avg
-1195.54%
5Y Avg
-797.02%
Market Cap
$61819.00
Gross Margin
-60.46%
TTM Avg
-17.77%
3Y Avg
23.60%
5Y Avg
-269.73%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Niki BioSolutions, Inc. (NIKI) | $381125.00 | 0.00% | 0.00% | -28.09% | -49.42% |
| XORTX Therapeutics Inc. (XRTX)vs › | $481786.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| SciSparc Ltd. (SPRC)vs › | $243502.00 | 73.71% | 56.22% | 66.21% | 71.99% |
| HCW Biologics Inc. (HCWB)vs › | $556226.00 | 20.00% | 28.69% | 28.89% | 35.93% |
| Silexion Therapeutics Ltd. (SLXN)vs › | $108771.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Psyence Biomedical Ltd. (PBM)vs › | $96046.00 | N/A | 0.00% | 0.00% | 0.00% |
| CDT Equity Inc. (CDT)vs › | $669223.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| PRF Technologies Ltd. (PRFX)vs › | $72318.00 | -4864.71% | -2432.36% | -1195.54% | -797.02% |
| Akanda Corp. (AKAN)vs › | $61819.00 | -60.46% | -17.77% | 23.60% | -269.73% |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30664.00 | -11.45% | 3.36% | 12.08% | 7.57% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-06-30 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-06-30 | -154.16% |
| 2022-12-31 | -70.53% |
| 2022-06-30 | -110.91% |
| 2021-12-31 | -57.74% |
| 2021-06-30 | -92.35% |
| 2020-12-31 | -107.32% |
| 2020-06-30 | -248.11% |
| 2019-12-31 | -483.45% |
| 2019-06-30 | -54.63% |
| 2018-12-31 | 17.07% |
| 2018-06-30 | 14.67% |
